SAVE THE DATES
We are pleased to announce that Medicilon will attend the EFMC‑ACSMEDI Medicinal Chemistry Frontiers 2026 – a premier joint symposium on medicinal chemistry organised by the European Federation for Medicinal Chemistry and Chemical Biology (EFMC) and the ACS Division of Medicinal Chemistry (ACSMEDI).
The meeting brings together experts in medicinal chemistry and synthetic chemistry, together with scientists active in computer‑assisted drug design (CADD), biology, DMPK, pharmacology, and early toxicology.
We look forward to showcasing how our integrated preclinical CRO services can accelerate your program from hit to IND.
When: June 22-25, 2026
Where:Trinity Conference Centre, Trinity College Dublin, Ireland
Meet our team on site:
- Dr. Paul G.J. van Stralen – VP Strategic Collaborations EMEA
- Dr. Jian Liu – VP of Business Development
What We Offer – Integrated CRO Services from Idea to IND
Medicilon provides chemistry, biology, DMPK, safety assessment, CMC and formulation under one roof – with a track record of supporting 650+ IND approvals worldwide.
Medicinal Chemistry & Custom Synthesis
- Hit‑to‑lead, lead optimisation, SAR studies, parallel synthesis
- CADD, SBDD, FBDD, AI‑augmented design
- PROTAC platform: E3 ligands, linkers, E3 ligands, spirocyclic linkers
- ADC platform: payloads, linkers, payload‑linker combinations
- Nucleic acid platform: unique monomers for oligonucleotide synthesis
- Custom synthesis (mg to kg, including GMP): stable isotope internal standards, metabolites, impurities
- Process chemistry: route scouting and optimization, kilo‑scale GMP manufacturing
In Vivo Pharmacology & Translational Models
- >1,000 in vivo efficacy models (oncology CDX/PDX/orthotopic/ humanized; non‑oncology: metabolic, CNS, cardiovascular, digestive, ophthalmic…)
- PK/PD, biomarker‑driven pharmacology
CMC & Formulation Development – Integrated from API to Drug Product
- API process development from gram to multi‑tone GMP manufacturing
- Formulation types: solids, semi‑solids, liquids, special forms
- Inhalation, ophthalmic, topical, oral, aseptic liquid capabilities with full analytical methods
- GMP workshops for solid, semi‑solid, inhalation formulations; GMP analytical lab
- Quality research platform covering release testing, stability, method validation, and specific tests for each dosage form
Flexible Collaboration & Global Regulatory Support
- FTE / FFS models – proven through partner awards (e.g., “Excellent Service Team” for Chemistry FTE)
- GLP certified by NMPA, FDA, OECD; AAALAC accredited
- China‑US dual‑filing capabilities; SEND data conversion for FDA
- Seamless workflow – unified project management, no tech‑transfer gaps
- We look forward to discussing how Medicilon can be your trusted partner in medicinal chemistry, CMC and beyond – all the way from Idea to IND.
See you in Dublin!
Meet the Medicilon team by filling out the form below:
